Andrew Hindman

2018

In 2018, Andrew Hindman earned a total compensation of $1.2M as Chief Business Officer at Acorda Therapeutics, a 28% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$641,580
Salary$504,167
Other$8,250
Total$1,153,997

Hindman received $641.6K in non-equity incentive plan, accounting for 56% of the total pay in 2018.

Hindman also received $504.2K in salary and $8.3K in other compensation.

Rankings

In 2018, Andrew Hindman's compensation ranked 8,486th out of 14,244 executives tracked by ExecPay. In other words, Hindman earned more than 40.4% of executives.

ClassificationRankingPercentile
All
8,486
out of 14,244
40th
Division
Manufacturing
3,376
out of 5,765
41st
Major group
Chemicals And Allied Products
1,269
out of 2,128
40th
Industry group
Drugs
1,059
out of 1,817
42nd
Industry
Biological Products, Except Diagnostic Substances
200
out of 339
41st

Pay ratio

Andrew Hindman's Pay$1,153,997
Median Employee's Pay$202,725
Pay Ratio

6

to 1

In 2018, the annual total compensation of Andrew Hindman was $1,153,997.

The annual total compensation of the median employee at Acorda Therapeutics was $202,725.

The ratio of Andrew Hindman's pay to the pay of median employee was therefore 6 to one.

Source: SEC filing on April 26, 2019.

Hindman's colleagues

We found five more compensation records of executives who worked with Andrew Hindman at Acorda Therapeutics in 2018.

2018

Ron Cohen

Acorda Therapeutics

Chief Executive Officer

2018

Jane Wasman

Acorda Therapeutics

General Counsel

2018

Burkhard Blank

Acorda Therapeutics

Chief Medical Officer

2018

Lauren Sabella

Acorda Therapeutics

Chief Commercial Officer

2018

David Lawrence

Acorda Therapeutics

Chief, Business Operations and Principal Accounting Officer

News

You may also like